For localized information and support, would you like to switch to your country-specific website for {0}?
Article
proCardio podcast series
Podcast series on the newest advancements in the management of cardiometabolic diseases
Welcome to the proCardio podcast series by Roche, offering an exploration of advancements in the prevention, screening, diagnosis, and implementation strategies for cardiometabolic disease management.
Featuring interviews with leading cardiologists, the series covers critical topics including insights on cardiac biomarkers' use from real-world evidence, translating heart failure guidelines into practice, enabling early diagnosis, and discussing innovative trials.
Join the host Konstantin Schmidt, SciComms Manager at Roche Diagnostics, as he engages with the brightest minds in the field to bring you 7 episodes, packed with expert insights and practical knowledge to help enhance clinical care for cardiometabolic diseases.
Prevention and Screening
Real world evidence and opportunities for early intervention in heart failure
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Real world evidence and opportunities for early intervention in heart failure for people living with diabetes
Interview with Dr. Safia Chatur on the importance of real world evidence and what it tells us about the use of biomarkers (such as natriuretic peptides) in clinical routine for heart failure identification in people living with diabetes.
Implementation of NT-proBNP based screening for heart failure prevention in people with diabetes
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Implementation of NT-proBNP based screening for heart failure prevention in people with diabetes
Interview with Prof. Rodica Pop-Busui on her extensive experience in implementing a heart failure screening program in a university network, translating guideline recommendation into clinical care.
Value of Troponins in Predicting Cardiovascular Disease Risk in the General Population
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Value of Troponins in Predicting Cardiovascular Disease Risk in the General Population
Interview with Dr. Raphael Twerenbold on cardiometabolic risk assessment in the general population. Current standard of care and its limitations are explored along with the advantages of incorporating biomarkers in existing protocols.
Diagnostics and Implementation
Coming soon...
CarDiaLogue unites the passion for cardiology and diagnostics in an engaging dialogue
Join the #CarDiaLogue today and sign up for updates.
CarDiaLogue brings you the latest insights and valuable perspectives from some of the sharpest minds in cardiology to complement your specialist skills.